Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
426 Ergebnisse
| FE1AXS | Vertex Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 35,412 % | 0,199 | -0,068 | 8,793 | 18.12.2026 | 0,100 | Société Générale | ||
| VJ121U |  | Vertex Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 37,905 % | 0,250 | -0,077 | 7,204 | 15.01.2027 | 0,100 | Vontobel | |
| VJ58F4 | | Vertex Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 36,933 % | 0,208 | -0,073 | 8,368 | 18.12.2026 | 0,100 | Vontobel | |
| VY41Y2 | | Vertex Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600,000 | call | Vertex Pharmaceuticals Inc. | - | 38,900 % | 0,363 | -0,072 | 4,792 | 17.06.2027 | 0,100 | Vontobel | |
| JY2HTR | Vertex Pharmaceuticals Inc./OS/Call [620]/JPMD | - | - | 620,000 | call | Vertex Pharmaceuticals Inc. | - | 39,808 % | 0,227 | -0,076 | 7,088 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY32H7 | Vertex Pharmaceuticals Inc./OS/Call [640]/JPMD | - | - | 640,000 | call | Vertex Pharmaceuticals Inc. | - | 39,281 % | 0,208 | -0,072 | 7,322 | 15.01.2027 | 0,100 | JP Morgan | ||
| GU1HQA | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 47,609 % | 0,063 | -0,057 | 13,053 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GW31A1 | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 35,706 % | 0,261 | -0,056 | 5,724 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW31A0 | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 37,501 % | 0,158 | -0,056 | 8,174 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW31BQ | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 37,071 % | 0,209 | -0,058 | 6,751 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW8VG4 | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 38,089 % | 0,377 | -0,056 | 3,926 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW97T7 | Vertex Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 60,986 % | 0,043 | -0,067 | 14,934 | 21.08.2026 | 0,100 | Goldman Sachs | ||
| MK35A2 | | Vertex Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 43,813 % | 0,178 | -0,008 | 7,473 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MR3C34 | | Vertex Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 41,331 % | 0,246 | -0,007 | 5,886 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR3C33 | | Vertex Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 40,401 % | 0,313 | -0,007 | 4,879 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MR3C35 | | Vertex Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Vertex Pharmaceuticals Inc. | - | 42,344 % | 0,395 | -0,006 | 3,647 | 17.12.2027 | 0,010 | Morgan Stanley | |
| JY27MK | Vertex Pharmaceuticals Inc./OS/Call [660]/JPMD | - | - | 660,000 | call | Vertex Pharmaceuticals Inc. | - | 40,132 % | 0,167 | -0,062 | 7,601 | 15.01.2027 | 0,100 | JP Morgan | ||
| GJ9P7M | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 41,026 % | 0,098 | -0,046 | 8,988 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GJ9U7U | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 39,529 % | 0,129 | -0,052 | 8,128 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GV70J9 | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 53,851 % | 0,047 | -0,050 | 12,179 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GV8H5W | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 35,497 % | 0,208 | -0,050 | 6,105 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW01DP | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 37,703 % | 0,328 | -0,053 | 4,142 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW1W63 | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 37,873 % | 0,152 | -0,048 | 7,144 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW85MX | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 46,642 % | 0,059 | -0,045 | 11,187 | 16.10.2026 | 0,100 | Goldman Sachs | ||
| GW937Q | Vertex Pharmaceuticals Inc./OS/Call [700]/GOLDS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 69,655 % | 0,043 | -0,077 | 12,992 | 21.08.2026 | 0,100 | Goldman Sachs | ||
| MK129T | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 47,427 % | 0,141 | -0,007 | 7,341 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM0CJ2 | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 40,510 % | 0,238 | -0,006 | 5,280 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MN3THD | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 67,720 % | 0,102 | -0,012 | 8,680 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN3THE | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 41,943 % | 0,347 | -0,006 | 3,841 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MR3C36 | | Vertex Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700,000 | call | Vertex Pharmaceuticals Inc. | - | 43,083 % | 0,194 | -0,006 | 6,039 | 19.03.2027 | 0,010 | Morgan Stanley | |
| GW315E | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750,000 | call | Vertex Pharmaceuticals Inc. | - | 38,891 % | 0,114 | -0,040 | 7,401 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW315D | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750,000 | call | Vertex Pharmaceuticals Inc. | - | 36,094 % | 0,160 | -0,042 | 6,400 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW316C | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750,000 | call | Vertex Pharmaceuticals Inc. | - | 41,692 % | 0,087 | -0,040 | 8,376 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW3NCK | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750,000 | call | Vertex Pharmaceuticals Inc. | - | 37,983 % | 0,266 | -0,047 | 4,385 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GN01XC | Vertex Pharmaceuticals Inc./OS/Call [750]/GOLDS | - | - | 750,000 | call | Vertex Pharmaceuticals Inc. | - | 78,779 % | 0,036 | -0,074 | 11,860 | 21.08.2026 | 0,100 | Goldman Sachs | ||
| GV0M67 | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 44,968 % | 0,061 | -0,036 | 8,932 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GV0M6N | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 43,325 % | 0,065 | -0,033 | 8,485 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GV9FAY | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 37,339 % | 0,118 | -0,034 | 6,628 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GV9FBX | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 68,158 % | 0,039 | -0,054 | 10,074 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GW03TU | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 38,540 % | 0,228 | -0,044 | 4,515 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW1W5T | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 39,908 % | 0,086 | -0,033 | 7,616 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW90EY | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 55,648 % | 0,039 | -0,038 | 10,122 | 16.10.2026 | 0,100 | Goldman Sachs | ||
| GW981Z | Vertex Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 89,729 % | 0,029 | -0,068 | 11,000 | 21.08.2026 | 0,100 | Goldman Sachs | ||
| MK67TE | | Vertex Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 55,931 % | 0,107 | -0,007 | 6,715 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MR3C39 | | Vertex Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 47,865 % | 0,139 | -0,006 | 5,945 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR3C37 | | Vertex Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 43,850 % | 0,171 | -0,005 | 5,353 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MR3C38 | | Vertex Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Vertex Pharmaceuticals Inc. | - | 43,558 % | 0,268 | -0,006 | 4,029 | 17.12.2027 | 0,010 | Morgan Stanley | |
| GW9A8R | Vertex Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850,000 | call | Vertex Pharmaceuticals Inc. | - | 37,967 % | 0,102 | -0,032 | 6,713 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW9A8Y | Vertex Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850,000 | call | Vertex Pharmaceuticals Inc. | - | 40,633 % | 0,064 | -0,027 | 7,865 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW9J3J | Vertex Pharmaceuticals Inc./OS/Call [900]/GOLDS | - | - | 900,000 | call | Vertex Pharmaceuticals Inc. | - | 75,714 % | 0,026 | -0,041 | 9,664 | 18.09.2026 | 0,100 | Goldman Sachs |